The Supreme Court unanimously rejected the challenge to federal mifepristone access rules on June 13, 2024. NPR, AP, and Fox News all reported that the justices ruled the anti-abortion doctors who sued lacked standing.
Coverage across the spectrum agreed that the decision left existing FDA rules in place and preserved the abortion pill's nationwide availability for the time being. The ruling did not resolve every future legal avenue, but it ended the most immediate national threat to access.
Fox News and AP both noted that the Court reached the case on procedural grounds, while NPR focused more on how central mifepristone had become to abortion access after Dobbs.